Search
for

    Sort by

    Research 25

    1. Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT) Kardiologiia · 2020 · 24 citations
    2. Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals Journal of The American Academy of Dermatology · 2020 · 6 citations
    3. An update of anti-viral treatment of COVID-19 Turkish Journal of Medical Sciences · 2021 · 51 citations
    4. COVID‐19, androgens, and androgenic alopecia Dermatological reviews · 2020 · 6 citations
    5. Harmless Herbs? A Review of the Recent Literature The American Journal of Medicine · 1998 · 581 citations
    6. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Communications biology · 2020 · 113 citations
    7. Are sex discordant outcomes in COVID-19 related to sex hormones? Seminars in Oncology · 2020 · 42 citations
    8. Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract Pharmacology Research & Perspectives · 2020 · 15 citations
    9. Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore Pharmacology Research & Perspectives · 2019 · 13 citations
    10. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity Journal of medicine and life · 2022 · 8 citations
    11. TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target Medeniyet Medical Journal · 2025 · 4 citations
    12. Erythema multiforme in a Central American tapir (Tapirus bairdii) calf, clinical case report Frontiers in veterinary science · 2023
    13. Hair Loss and Androgen’s Role in the Era of COVID-19 International Journal of Biomedicine · 2022
    14. Androgen sensitivity gateway to COVID‐19 disease severity Drug Development Research · 2020 · 123 citations
    15. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign” Journal of The American Academy of Dermatology · 2020 · 119 citations
    16. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients Cell Transplantation · 2020 · 38 citations
    17. Testosterone in COVID-19: An Adversary Bane or Comrade Boon Frontiers in Cellular and Infection Microbiology · 2021 · 23 citations
    18. The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor Tumor Biology · 2021 · 16 citations
    19. Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems Frontiers in Molecular Biosciences · 2021 · 13 citations
    20. Antiandrogens as Therapies for COVID-19: A Systematic Review Cancers · 2024 · 6 citations
    21. COVID-19: The question of genetic diversity and therapeutic intervention approaches Genetics and Molecular Biology · 2021 · 4 citations
    22. The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis Medicine · 2025 · 2 citations
    23. Response Surface Methodology (RSM) approach to formulate and optimize the bilayer combination tablet of Tamsulosin and Finasteride Saudi pharmaceutical journal · 2024
    24. COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role? Journal of men's health · 2023
    25. Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical) Cureus · 2021 · 41 citations